Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care Treatment
NCT ID: NCT02952846
Last Updated: 2022-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2016-05-31
2022-04-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Describe the frequency and severity of withdrawal syndrome in a population of paediatric intensive care patients.
2. Test whether implementation of an algorithm for tapering of analgosedation changes the frequency and severity of withdrawal symptoms in the same population.
3. Investigate how the health care providers experience having to adhere to such an algorithm.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protocolized Sedative Weaning VS. Usual Care in Pediatric Critically Ill, RCT
NCT03018977
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478
Implementation and Evaluation of a Pediatric Nurse-driven Sedation Protocol in a PICU
NCT02829710
Paediatric Ards Neuromuscular Blockade Study
NCT02902055
Cycling of Sedative Infusions in Critically Ill Pediatric Patients
NCT01333059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For part three of the study, focus group interviews will be used.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before algorithm
Observational
No interventions assigned to this group
After algorithm
Algorithm for tapering of analgosedation
Algorithm for tapering og analgosedation
Algorithm for tapering og analgosedation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Algorithm for tapering og analgosedation
Algorithm for tapering og analgosedation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treated in PICU
* Infusion of opioids and/or benzodiazepins for 5 days or more.
Exclusion Criteria
* Cognitive/neurological disturbance caused by a disease
* Multiple disabilities
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gunnar Bentsen
Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gunnar bentsen, MD PhD
Role: STUDY_CHAIR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital, Rikshospitalet
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016_ASWISPIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.